We stained duplicate slides with anti-ephrin-A1 or anti-EphA2 antibodies that were validated using mammary tissue from genetic deletion mouse models (Figure S7) and quantified the percent positive tumor epithelium and relative staining intensity using a computer-based Ariol platform. Here, EFNA1 is linked to neoplasm.